Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SRD5A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC25A37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927330 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SMIM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CORO2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RAB3D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF391 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C3orf56 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FTCDNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC17A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GTDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABHD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on